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Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to
Influenza in Their Infants. Isaac Benowitz.
The aim of this study was to determine whether giving influenza vaccine to pregnant
women can reduce the incidence of hospitalization due to influenza in their infants in the
first year of life. This was a matched, hospital-based case-control study at Yale-New Haven
Children’s Hospital. Case and control subjects were all aged <12 months at the time of
their hospital admission from 2000 to 2009. All subjects were identified through hospital
records. Cases consisted of infants admitted due to influenza infection. Infants who did not
have influenza infection at the time of hospitalization matched to cases by date of birth and
date of hospitalization (both within 4 weeks before or after) were used as controls. We con-
tacted parents of all subjects to collect information on the subjects’ health and home setting
and to get permission to review subjects’ and mothers’ hospital records and outpatient med-
ical records. These were used to determine whether the subject or mother had received in-
fluenza vaccine or other vaccines and to identify underlying health conditions that could
predispose to severe influenza infection. Conditional logistic regression was used to de-
termine the relative risk of hospitalization for influenza infection for mothers who did or
did not receive influenza vaccine during pregnancy or other times. The mothers of two (2.2
percent) of 91 cases and 31 (19.9 percent) of 156 controls aged <6 months and one (4.6 per-
cent) of 22 cases and two (5.6 percent) of 36 controls aged >6 months received influenza
vaccine during pregnancy. The effectiveness of influenza vaccine given to mothers in preg-
nancy in preventing hospitalization in their infants aged <6 months, adjusted for potential
confounders, was 91.5 percent (95 percent CI: 61.7 percent-98.1 percent, p = 0.001). In-
fluenza vaccine given to pregnant women was 91.5 percent effective in preventing hospi-
talization of their infants due to influenza in the first 6 months of life.
Development  of  a  Nanoparticulate  Drug  Delivery  Vehicle  for  Retinoic  Acid. 
Noah Capurso.
Retinoic acid (RA) is a small molecule capable of shunting developing T cells away from
the Th17 lineage and toward the Treg phenotype, making it a potentially useful therapeutic for
autoimmune and inflammatory diseases. However, therapy can be complicated by systemic tox-
icity and unpredictable bioavailability, making a targeted drug delivery vehicle for local therapy
desirable. A promising approach is the use of nanoparticles, which have been demonstrated to in-
crease potency and decrease toxicity of therapies in a variety of disease models, including Th17
mediated diseases. We therefore constructed a nanoparticulate drug delivery platform from
poly(lactic-co-glycolic acid) (PLGA) capable of encapsulating and releasing RA. Here we report
the fabrication, characterization, and in vitro bioactivity of this platform. We demonstrate that RA
containing PLGA nanoparticles suppress IL-17 and IFN-gamma production and ROR-gamma(t)
expression in T cells polarized toward the Th17 phenotype in vitro with similar potency to that
of free drug. Furthermore, we show that these particles enhance TGF-beta dependent Foxp3 ex-
pression and IL-10 production of T cells in vitro with similar potency to free RA. Finally, we
demonstrate that T cells polarized toward the Th17 phenotype in the presence of free RA and
nanoparticulate RA have similarly suppressed ability to induce IL-6 production by fibroblasts. Our
findings demonstrate the feasibility of RA delivery via biodegradable nanoparticles and represent
an exciting technology for the treatment of autoimmune and inflammatory diseases.Thesis award recipients 278
Platelet Induction of Monocyte to Dendritic Cell Differentiation. Tyler Durazzo.
We hypothesized that activated platelets induce monocyte-to-dendritic cell (DC) dif-
ferentiation. The aims of this study were to: 1) determine the role that platelets play, if any,
in the signaling of monocyte to DC differentiation; 2) determine the mechanism of action
by which platelets induce monocyte-to-DC differentiation; and 3) use this knowledge to
advance cancer immunotherapy.
To achieve these ends: 1) Parallel-plate flow chambers were designed to deliver mono-
cytes at a controlled level of platelet exposure, with phenotype and genotype assessed fol-
lowing overnight incubation; 2) blocking antibodies and proteins were used to assess for the
significance of particular monocyte-platelet interactions in the mechanism; and 3) addi-
tional experiments and mathematical modeling were performed to extrapolate our new
mechanistic knowledge to enhance extracorporeal photochemotherapy (ECP), an im-
munotherapy in clinical use.
Results showed direct correlation between platelet exposure and level of DC differen-
tiation following overnight incubation (p < 0.0001). A detailed mechanism was determined
involving p-selectin and other proteins expressed by activated platelets. This mechanistic
knowledge permitted intelligent modification of ECP.
We conclude that platelets induce monocyte-to-DC differentiation. The rapidity and ef-
ficiency of this induction suggests the possibility that this is a physiologic mechanism em-
ployed in vivo for DC differentiation. Possible exploitation of this mechanism may prove
beneficial in cancer immunotherapy.
Determining the Fate of Bone Marrow Mononuclear Cells in Tissue Engineered
Vascular Grafts Using MRI. Jamie Keiko Nicole Harrington.
The most widely used method of creating tissue engineered vascular grafts (TEVGs) for
in  vivo implantation  consists  of  seeding  autologous  bone  marrow  cells  (BMCs)  onto
biodegradable scaffolds. In this model of TEVG development, it has traditionally been thought
that stem cells and endothelial progenitor cells (EPCs) within the seeded bone marrow popu-
lation gave rise to the cells of the neovessel. Recent work in our lab indicates that the seeded
BMCs are not incorporated into the neovessel and are actually rapidly lost from the implanted
scaffold. Here we show the feasibility of noninvasively monitoring this process by tracking
ultrasmall superparamagnetic iron oxide (USPIO)-labeled macrophages with MRI. Murine
macrophages were labeled with USPIO through in vitro culture in media containing 2mg/ml
of USPIO. The USPIO-labeled macrophages were seeded onto polyglycolic acid (PGA) scaf-
folds that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.
Images were then obtained using a 4.7T Bruker horizontal bore scanner with an optimized
RARE spin echo sequence and a multislice-multiecho sequence to determine the T2 relaxation
time with serial imaging. The T2 signal was found to be significantly lower immediately fol-
lowing implantation of the USPIO labeled scaffolds (T2 = 44ﾱ6.8 vs. 71ﾱ10.2) but increased
rapidly to a value identical to that of control implants seeded with unlabeled macrophages
(T2 = 63ﾱ12 vs. 63ﾱ14). This strongly indicates the rapid loss of seeded cells from the scaf-
folds, a finding verified using Prussian blue staining for iron containing macrophages on his-
tological sections of explanted TEVGs. Our findings provide further support for the paradigm
shift away from BMC neovessel incorporation toward the host cell-based population of im-
planted TEVGs. Furthermore, we demonstrate one of the first successful applications of non-
invasive MR imaging for serial study of cellular level processes in tissue engineering.
Once-Daily vs. Twice-Daily Dosing in HIV-infected Pregnant Women at Yale-
New Haven Hospital. Terri Quan Huynh.
The current recommendations for antiretroviral-na￯ve patients support initiating HIV-
infected patients on a once-daily (QD) regimen. However, seropositive pregnant womenThesis award recipients 279
are often initiated or changed to a twice-daily (BID) regimen due to the historical prefer-
ence of zidovudine. Our 10-year retrospective cohort study aims to compare the efficacy and
safety between QD (n = 20) and BID (n = 50) regimens in HIV-infected pregnant women.
We hypothesize there will be no difference between the two dosing regimens. Using mul-
tivariate regression analysis to adjust for confounding variables, we found no statistical dif-
ference (adjusted odds ratio 0.26, 95 percent confidence interval 0.1,1.2; p = 0.099) in the
quantity of patients who achieved a viral load < 50 copies/mL by the time of delivery be-
tween the QD group (80 percent) and the BID group (66 percent). Similarly, we found no
difference in maternal or neonatal adverse effects, including preterm delivery, low birth
weight, and pregnancy complications between our two cohorts. In summary, our study sug-
gests QD dosing is non-inferior to BID dosing and may be a safe alternative for the HIV-
infected pregnant population.
Tuberculosis Infection Control in Rural South Africa: Information, Motivation,
and Behavioral Skills. Zahir Kanjee.
Healthcare-associated tuberculosis (TB) transmission occurs in resource-limited
health facilities, putting patients and healthcare workers (HCWs) at risk. TB infection con-
trol (IC) can prevent such transmission but is inadequately implemented. We attempted to
better characterize HCW TB IC implementation. We hypothesized that TB IC implemen-
tation would correlate in the manner predicted by the Information-Motivation-Behavioral
skills (IMB) behavioral model. We conducted direct observations of TB IC behavior and
staff questionnaires of TB IC IMB and behavior at two district hospitals (Church of Scot-
land Hospital, COSH, and Charles Johnson Memorial Hospital, CJM) in rural South Africa.
Direct observations were conducted on 10 to 14 consecutive working days. Observed TB
IC practices varied greatly by department (natural ventilation: 50.7-97.0 percent, respira-
tor use: 5.0-100.0 percent). Questionnaires were completed by 123 HCWs at COSH and
75 at CJM. Information levels were generally high at both hospitals. Motivation responses
were generally appropriate, though 29.4 percent would not be bothered “very much” by
catching TB, and 22.8 percent thought TB IC was not worth the effort. Behavioral skills
assessment indicated that HCWs found the majority of TB IC procedures to be easy to
perform, though respondents highlighted several discrete tasks as being relatively diffi-
cult, especially those relating to personal HIV testing and relocation to low-risk depart-
ments if HIV-positive. When in high-risk TB areas of the hospital, more than half of
respondents claimed to “always” wear a respirator (54.3 percent), instruct patients on cough
hygiene (63.0 percent), and ensure effective natural ventilation (67.4 percent). Most (74.0
percent) knew their HIV status (81.0 percent at COSH, 63.8 percent at CJM, p = 0.012).
Correlations were noted between self-reported TB IC implementation and several IMB
variables, particularly those related to social support. A social support Motivational sub-
scale correlated with self-reported respirator use (p = 0.002), cough hygiene instruction (p
= 0.001), and natural ventilation (p = 0.006). A global model was created to compare IMB
variables to aggregated self-reported TB IC behaviors. The only significant global scale
variable was Motivation as a covariate of Behavioral skills (p < 0.000). IMB models were
created for self-reported respirator use, cough hygiene instruction to patients, natural ven-
tilation implementation, and knowledge of personal HIV status. The respirator IMB model
performed much better than the others. Information did not vary significantly with other
variables in any of the models. Results suggest that rather than focusing on improving staff
information, efforts to increase TB IC implementation should focus on HCW Motivation
and Behavioral skills development. TB IC implementation in this study compared favor-
ably to other reports from the developing world. Social support, especially that of col-
leagues and supervisors, is an important element in ensuring better TB IC implementation,
which is crucial to preventing healthcare-associated transmission. Though individual mod-
els require refinement, IMB modeling offers a promising avenue for further research and
guiding interventions.Thesis award recipients 280
A  3’UTR  KRAS-Variant  as  a  Biomarker  of  Poor  Outcome  and  Platinum
Chemotherapy Resistance in Ovarian Cancer. Florence Kathleen Keane.
Purpose: Ovarian cancer has a poor prognosis, yet pathologic and clinical data do not
accurately predict which patients will ultimately succumb to the disease. We previously re-
ported an association between rs61764370, a germline functional variant in the 3’UTR of
the KRAS oncogene, and epithelial ovarian cancer (EOC) risk. Here we evaluate this vari-
ant as a biomarker of clinical outcome and chemotherapy resistance in EOC.  
Patients and Methods: Four groups of EOC patients with complete clinical data were
genotyped for the KRAS-variant and analyzed: Sporadic EOC patients (n = 451); BRCA
mutant EOC patients (n = 79); EOC patients treated with neoadjuvant chemotherapy (n =
122); and EOC patients treated adjuvantly with platinum-based chemotherapy after cy-
toreductive surgery (n = 292).  
Results: The KRAS-variant predicts significantly worse survival for EOC patients
over 55 years old by multivariate Cox regression analysis (HR = 1.71, 95 percent CI=1.09
- 2.69, p = 0.02). However, for the subgroup of EOC patients with known BRCA muta-
tions, the KRAS-variant did not predict altered outcome (HR = 0.994, CI = 0.28-3.56, p =
0.99). KRAS-variant positive EOC patients respond poorly to neoadjuvant carboplatin and
paclitaxel chemotherapy, having significantly more residual disease remaining after sur-
gery (OR = 26.27, CI = 1.56- 441.83, p = 0.0232). In addition, EOC patients that harbor the
KRAS-variant are more likely to be resistant to adjuvant platinum chemotherapy (OR =
2.86, CI = 1.13-7.23, p = 0.026). 
Conclusions: These findings expand the potential importance of the KRAS-variant in
EOC, from acting as a marker of risk to being a biomarker that predicts worse outcome, per-
haps due to its association with platinum resistance. These data may ultimately help lead to
treatment optimization and improved outcome for KRAS-variant positive EOC patients.
Association  Between  Disruption  of  Fibrin  Sheaths  Using  Percutaneous
Transluminal  Angioplasty  Balloons  and  Late  Onset  of  Central  Venous 
Stenosis. Nina Ni.
This study compares the rates of central venous stenosis in patients undergoing he-
modialysis who underwent disruption of fibrin sheath with percutaneous transluminal an-
gioplasty (PTA) balloons and those who underwent over-the-wire catheter exchange.
This study is a retrospective review of 209 PTA balloon disruption and 1,304 over-
the-wire catheter exchange procedures. Approval from the Human Investigations Commit-
tee was obtained for this study. Up to 10-year follow-up was performed. A χ2 test was used
to compare the rates of central venous stenosis after balloon disruption versus catheter ex-
change. A T-test was used to compare time to central venous stenosis development.
Of the 753 patients in the study, 127 patients underwent balloon disruption of fibrin
sheath and 626 had catheter exchange. Within the balloon disruption group, 18/127 patients
(14.2 percent) subsequently developed central venous stenosis, compared with 44/626 (7.0
percent) in the catheter exchange group (P < 0.01, χ2 test). Time to central venous stenosis
development was approximately 3 years in both groups and not significantly different (1,371
and 1,010 days, P = 0.20). Twenty-five point two percent of patients in the balloon disrup-
tion group had four or more subsequent catheter exchanges versus 12.6 percent in the
catheter exchange group (P < 0.01, χ2 test).
There is a possible association between PTA balloon disruption of fibrin sheath and late
onset central venous stenosis. Since venography was not routinely performed in catheter ex-
change patients, future randomized studies are necessary to confirm these findings.
Suffering Transfigured: Phenomenological Personalism in the Doctor-Patient
Relationship. Keri Ochs Oxley. 
From antiquity, one of the primary goals of medicine has been the alleviation of pa-
tients’ suffering. Despite remarkable advances in modern science and technology, patientsThesis award recipients 281
continue to experience suffering, which is frequently unnoticed and unaddressed by physi-
cians. 
Phenomenology incorporates an understanding of illness-as-lived, which provides the
physician with a view more expansive than the purely biomedical model of disease. There
exists a decisive gap between the way a physician thinks about disease and the way illness
is experienced by the patient. As a result, there is a separation between the “lifeworlds” of
the physician and patient. A fuller description of suffering in illness offers the physician an
expanded paradigm of illness to enable her to narrow the gap between her own lifeworld and
that of the patient. This thesis employs a clinically based phenomenological approach, ob-
serving the phenomena of disease and illness as they are encountered in the clinical setting,
the nucleus of which is the doctor-patient relationship.
Suffering is certainly something that should be eliminated by all reasonable means and
costs. It is also clear, however, that sometimes suffering is unavoidable in the patient’s ex-
perience of illness. We hold these two truths in tension. On the one hand, it is a duty for
physicians to try to alleviate unnecessary suffering. But what about inescapable suffering,
particularly in cases of chronic and terminal illness?  
Viktor Frankl notes that meaning can be a powerful avenue to the elevation of the
human person in moments of unavoidable suffering. This thesis proposes that suffering can
be transfigured by way of meaning and that physicians can play a powerful role toward this
end. The will to meaning is a means to gains such as love, self-transcendence, achievement
of a good, and the dignity of the person amid the losses experienced in suffering. This work
offers a novel contribution to the medical literature by demonstrating that unavoidable suf-
fering potentially can be transformed into a positive experience and that the doctor-patient
encounter can be instrumental in this pursuit. 
Rather than waiting for systemic changes in healthcare or medical education, this the-
sis argues that physicians can be instrumental in the alleviation and transformation of suf-
fering simply by adopting phenomenological personalism in the practice of medicine.
Premised on a heightened attentiveness to the patient’s lifeworld, phenomenological per-
sonalism serves as a catalyst for the patient’s discovery of meaning in unavoidable suffer-
ing. This approach does not exclude the biomedical model, but rather expands the lifeworld
of the physician so that she is able to acknowledge and address the uniqueness of the pa-
tient’s experience of suffering in illness. Thus, in moments of unavoidable suffering, a per-
sonal tragedy is transfigured into a human triumph.
A Human Culture Model of the Outer Blood-Retinal Barrier in Age-Related
Macular Degeneration. Veena Rao.
In age-related macular degeneration (AMD), the outer blood-retinal barrier is exposed
to various pathologic factors that can result in visual detriment. Two such stimuli include
serum, as may be seen in neovascular AMD, and proinflammatory cytokines, which may be
seen in neovascular and non-neovascular AMD. To examine effects of serum and cytokines
in disease, we adapted an outer blood-retinal barrier culture model using human fetal reti-
nal pigment epithelium (hfRPE) to investigate effects on tight junctions. Specifically, we fo-
cused on the claudin family and occludin tight junction proteins. HfRPE was cultured on
filters in growth medium until quiescent monolayers were formed; cells were then either
maintained in growth medium or switched to a serum-free medium. To study serum effects,
serum-free medium maintained cells were exposed to serum in apical, basal, or both media
chambers. To study cytokine effects, growth medium and serum-free medium cells were
exposed to TNF-α (10ng/mL), IL-1β (10ng/mL), or INF-γ (5ng/mL) in both media cham-
bers for 48 hours. Effects were measured at the functional level (transepithelial electrical re-
sistance; ion selectivity), mRNA level (RT-PCR, quantitative, real-time RT-PCR), and
protein level (immunoblotting, immunofluorescence). Claudin 19 was the predominant
claudin with mRNA expression >20ￗ that of any other claudin and exhibited protein ex-Thesis award recipients 282
pression in every cell. siRNA knockdown of claudin 19 resulted in functionally deficient
tight junctions. Apical, corresponding to subretinal, serum increased TER 2-3ￗ and altered
ion selectivity; basal serum had no effect. Apical serum effects were accompanied by in-
creases in occludin protein levels. TNF-α decreased TER and altered ion selectivity in both
media conditions; IL-1β and INF-γ had little or inconsistent effects. TNF-α exposure low-
ered claudin 19 but raised claudin 2 and occludin levels. Preventing the increase of claudin
2 with an siRNA did not alter the effect of TNF-α; this suggests TNF-α decreased TER by
a different mechanism. This culture model of the outer blood-retinal barrier in AMD sug-
gests claudin 19 is essential for the formation of functional tight junctions. Subretinal serum
results in a tightened outer blood-retinal barrier, which may be mediated by occludin; this
tightening may help limit the spread of disease. Inflammatory cytokines, particularly TNF-
α, appear to alter tight junction function and properties which may potentiate inflammatory
diseases such as AMD.
Regional Variation in Hospitalization Rates: Causes and Implications. Sachin
Jatin Shah.
Background: Admission rates vary by regions and states, but the extent by which vari-
ation in regional admission rates are related to variation in the medical need of populations
and the association with hospital outcomes is unknown. To address these issues, we exam-
ine two cardiovascular conditions that differ in physician discretion to admit: acute my-
ocardial infarction (AMI), less discretionary, and heart failure (HF), more discretionary. We
first determined whether regional cardiovascular risk factors predict admission rates and
then examined whether regional admission rates were related to 30-day risk-standardized
mortality and readmission rates (RSMRs and RSRRs). 
Methods: We used 2006-2008 Medicare ICD-9-CM claims data and the Medicare De-
nominator file to determine AMI and HF admission rates. The statewide prevalence of cardio-
vascular risk factors was obtained from the 2007 Behavioral Risk Factor Surveillance System.
First, the relationship between statewide AMI and HF admission rates and cardiovascular risk
factors was determined by a multivariate, least squares linear regression model. Second, hier-
archical logistic models were used to estimate hospital RSMRs and RSRRs and then were ag-
gregated to the level of hospital referral regions (HRRs). The correlation (R2) was obtained by
linear regression to characterize the relationship between both AMI and HF admission rates and
regional RSMRs and RSRRs. Where significant relationships were observed, “cross condi-
tion” analyses were performed, comparing admission rates of one condition against the RSMR
or RSRR of the other in an effort to identify potentially confounded relationships. 
Results: In the first analysis, cardiovascular risk factors explained 49 percent of the
variation observed in statewide AMI admission rates and 50 percent of the variation in HF
admission rates. In the second analysis, regional AMI admission rate was not correlated
with AMI RSMR (R2 0.01, 95 percent CI 0.00-0.04). Regional HF admission rate was in-
versely correlated with HR RSMR (R2 0.13, 95 percent CI 0.07-0.21). Regional AMI hos-
pitalization rate was weakly correlated with AMI RSRR (R2 0.05, 95 percent CI 0.02-0.11).
Regional HF admission rate was modestly correlated with HF RSRR (R2 0.25, 95 percent
CI 0.17-0.34). In the cross condition analyses, regional HF admission rate was not associ-
ated with AMI RSMR (R2 0.00, 95 percent CI 0.00-0.02) but was associated with AMI
RSRR (R2 0.25, 95 percent CI 0.17-0.34). 
Conclusion: Cardiovascular risk factors explain part, but not all, of the variation in
AMI and HF admission rates. The modest association between regional HF admission rate,
a more discretionary admission condition, and both AMI and HF RSRRs suggests a system
propensity to patients. The same was not seen true of AMI, a less discretionary admission
condition. The modest inverse relationship between regional HF admission rate and HF
RSMR, which was not observed with AMI RSMR, suggests an unmeasured confounder af-
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Optimal Tumor Sampling for Immunostaining of Biomarkers in Breast Carcinoma.
Juliana Tolles. 
Biomarkers, such as estrogen receptor, are used to determine therapy and prognosis in
breast carcinoma. Immunostaining assays of biomarker expression have a high rate of in-
accuracy; for example, estimates are as high as 20 percent for estrogen receptor. Biomark-
ers  have  been  shown  to  be  heterogeneously  expressed  in  breast  tumors,  and  this
heterogeneity may contribute to the inaccuracy of immunostaining assays. Currently, no
evidence-based standards exist for the amount of tumor that must be sampled in order to cor-
rect for biomarker heterogeneity.
The purpose of this study is to determine the optimal number of 20X fields that are nec-
essary to estimate a representative measurement of expression in a whole tissue section for
selected biomarkers: estrogen receptor (ER), human epidermal growth factor receptor 2
(HER2), AKT, extracellular signal-regulated kinase (ERK), ribosomal protein S6 kinase 1
(S6K1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), cytokeratin, and micro-
tubule-associated protein-Tau (MAP-Tau).
Two collections of whole tissue sections of breast carcinoma were immunostained for
biomarkers. Expression was quantified using Automated Quantitative Analysis (AQUA).
Simulated sampling of various numbers of fields (ranging from 1 to 35) was performed for
each marker. The optimal number was selected for each marker via resampling techniques
and minimization of prediction error over an independent test set.
The optimal number of 20X fields varied depending on the marker evaluated and
ranged between three to14 fields. More heterogeneous markers, such as MAP-Tau, required
a larger sample of 20X fields to produce representative measurement. The clinical impli-
cation of these findings is that small core needle breast biopsies may be inadequate to rep-
resent whole tumor biomarker expression for many markers. Also, for biomarkers newly
introduced into clinical use, especially if therapeutic response is dictated by level of ex-
pression, the optimal size of tissue sample must be determined on a marker-by-marker basis.
Rehospitalizations Among Elderly Patients with Thyroid Cancer Following
Thyroidectomy Are Prevalent and Costly. Charles Thompson Tuggle.
Thyroid cancer increases in incidence and aggressiveness with age. The elderly are
the fastest growing segment of the U.S. population. Reducing rates of rehospitalization
would lower cost and improve quality of care. The SEER-Medicare linked database was
used to identify patients >65 years with thyroid cancer who underwent thyroidectomy from
1997 to 2002. Patient and hospital characteristics were studied as predictors of rehospital-
ization. Outcomes were 30-day unplanned rehospitalization rate, cost, and length of stay
(LOS) of readmission. Of 2,127 patients identified, 69 percent were female, 84 percent had
differentiated thyroid cancer, and 52 percent underwent total thyroidectomy. Mean age was
74 years. One hundred seventy-one patients (8 percent) underwent 30-day unplanned re-
hospitalization. Rehospitalization was associated with increased comorbidity (17 percent for
a Charlson index of moderate/high vs. 6 percent for an index of none; P < .001), advanced
stage (22 percent for distant stage vs. 6 percent for local disease; P < .001), number of lymph
nodes examined (12 percent for >10 nodes vs. 7 percent for 0 nodes; P = .011), increased
LOS of index admission (mean of 4.8 days vs. 2.9 days; P < .001), and small hospital size
(9 percent vs. 6 percent for large hospitals; P = .026). Patients with a complication during
index hospital stay were more likely to be readmitted (14 percent vs. 6 percent; P < .001),
while patients who saw an outpatient medical provider following index discharge returned
less frequently (5 percent vs. 11 percent; P < .001). Forty-seven percent of readmissions
were for endocrine-related causes. Mean LOS and cost of rehospitalization were 3.5 days
and $5,921, respectively. Unplanned rehospitalization was associated with death at 1 year
compared to non-rehospitalized patients (18 percent vs. 6 percent; P < .001). Rehospital-
izations among Medicare beneficiaries with thyroid cancer following thyroidectomy are
prevalent and costly. Further study of predictors could identify high-risk patients for whomThesis award recipients 284
enhanced preoperative triage, improved discharge planning, and increased outpatient sup-
port might prove cost-effective.
Myelomeningocele and Hydrocephalus in Uganda: The Intersection of Culture,
Supportive Care, and Long-Term Survival. Ernest J. Wright. 
The treatment of neurosurgical disease in the developing world presents challenges on
numerous levels, not the least of which are the litany of logistical and infrastructural barri-
ers that stand in the way of delivering care. The scarcity of neurosurgeons combined with
limited mobility in developing countries requires a reconsideration of approaches to treat-
ment; this is particularly true of ventriculoperitoneal (VP) shunt insertion for the treatment
of hydrocephalus. While VP shunt implantation is the mainstay of treatment in the United
States, it is prone to failure requiring rapid access to neurosurgical care making shunt de-
pendency a dangerous proposition in this setting. Endoscopic third ventriculostomy (ETV)
offers an alternative to VP shunt dependency and has been shown to be effective in treat-
ing hydrocephalus at intervals of up to 14 months. 
The purpose of this study is to compare the 5-year survival for children treated with
endoscopic third ventriculostomy (ETV) to those treated with ventriculoperitoneal (VP)
shunt implantation for myelomeningocele-associated hydrocephalus. Because of the well-
known dangers of shunt dependency, it is hypothesized that patients treated with ETV will
have a survival advantage when compared with patients treated with VPS at a follow-up in-
terval of 5 years. 
In order to address this hypothesis, a retrospective observational study of children
treated with ETV or VP shunt implantation for myelomeningocele-related hydrocephalus at
the CURE Children’s Hospital of Uganda was carried out, including a control group con-
sisting of myelomeningocele patients who had not developed hydrocephalus. 
Survival status was determined for 128 of 131 study participants (98 percent). Forty-
seven of 128 (37 percent) of patients had expired at 5 years post-treatment, and 55 of 128
(42 percent) patients had expired at a mean follow-up interval of 84.4 months. Only two
cases of death were attributable to the development of hydrocephalus, none as a result of
treatment failure. Kaplan-Meier survival analysis found no statistically significant rela-
tionship between survival and method of treatment for hydrocephalus (p = 0.45), sex of pa-
tient (p = 0.53), HIV status (p = 0.69), age at repair (p = 0.34), or myelomeningocele level
(p = 0.12). Survival analysis performed for districts with community based rehabilitation
(CBR) programs and districts without CBR programs revealed a significant interaction (p
= 0.001). 
The uniformly high mortality across all groups suggests that the chief causes of long-
term mortality are both powerful and independent of hydrocephalus. The only correlation
with survival identified in this study, the presence of a CBR program providing in-home re-
habilitation, fulfills both of these criteria: Myelomeningocele patients require long-term re-
habilitation regardless of the development of hydrocephalus, and these programs exert a
powerful influence on survival. This substantial difference in long-term survival highlights
the fact that children in communities without CBR programs are not receiving life-saving
supportive care, in part due to a lack of parental understanding of the need for longitudinal
care. Established cultural beliefs about myelomeningocele, hydrocephalus, and disability in
general also hampered efforts to improve survival. Understanding the practical barriers to
the delivery of care in a developing country as well as the cultural mores through which dis-
eases are understood are critical to effectively treating disease across cultures and conti-
nents.